NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 5 filers reported holding NOVAVAX INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $270,000 | -73.5% | 1,300 | -99.1% | 0.00% | -33.3% |
| Q2 2016 | $1,018,000 | +182.0% | 140,000 | +100.0% | 0.01% | +20.0% |
| Q1 2016 | $361,000 | -28.2% | 70,000 | +16.7% | 0.01% | -28.6% |
| Q4 2015 | $503,000 | -54.8% | 60,000 | -40.0% | 0.01% | -46.2% |
| Q2 2015 | $1,114,000 | +7.7% | 100,000 | -20.0% | 0.01% | +8.3% |
| Q1 2015 | $1,034,000 | +39.5% | 125,000 | 0.0% | 0.01% | +50.0% |
| Q4 2014 | $741,000 | +77.7% | 125,000 | +25.0% | 0.01% | +60.0% |
| Q3 2014 | $417,000 | -9.7% | 100,000 | 0.0% | 0.01% | +25.0% |
| Q2 2014 | $462,000 | +69.9% | 100,000 | +66.7% | 0.00% | 0.0% |
| Q1 2014 | $272,000 | -18.3% | 60,000 | -7.7% | 0.00% | 0.0% |
| Q4 2013 | $333,000 | -8.0% | 65,000 | -43.5% | 0.00% | -20.0% |
| Q3 2013 | $362,000 | +402.8% | 115,000 | +228.6% | 0.01% | +400.0% |
| Q2 2013 | $72,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |